Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gentamicin in Hereditary Ichthyosis
NCT06362447Phase 2Not yet recruiting
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Sep 2024
- Primary completion
- Apr 2026
- Modality
- Nanoparticles, Implantable Devices, Transdermal Patches
- Countries
- 1
01
Overview
A Phase 2 trial of gentamicin in Hereditary ichthyosis, sponsored by Centre hospitalier universitaire de Toulouse. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
gentamicin
03
Conditions
Hereditary ichthyosis
Beyond the preview
Go deeper on NCT06362447.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06362447.